Atovaquone Proguanil patent revoked & Glenmark launches first UK generic

Glenmark Generics (Europe) announced the first generic launch of Atovaquone Proguanil in the UK following the revocation of the Malarone patent in the HC in the UK.

February 08, 2013 / 10:37 IST

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated February 07, 2013 titled "Atovaquone Prognanil (Malarone®) patent revoked & Glenmark launches first UK generic". Glenmark Generics (Europe) announced the first generic launch of Atovaquone Proguanil in the UK following the revocation of the Malarone patent in the HC in the UK. Source : BSE

Read all announcements in Glenmark

first published: Feb 8, 2013 10:37 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Atovaquone Proguanil patent revoked & Glenmark launches first UK generic

Glenmark Generics (Europe) announced the first generic launch of Atovaquone Proguanil in the UK following the revocation of the Malarone patent in the HC in the UK.

GP08